Abstract
Objective: To determine if Motivational Interviewing (MI) versus health education (HE) elicited different types of client language and whether these differences were associated with outcomes in a randomized clinical trial (RCT) for cessation induction among people who smoke with low motivation to quit. Methods: A secondary data analysis was conducted using data from the MI and HE arms of a trial in which people who smoke (N = 202) with low desire to quit were randomly assigned to four sessions of MI, HE or brief advice. Mediation analyses examined two types of client language: change talk (CT) and a novel form of client speech called “learning talk” (LT). Outcomes were assessed at baseline, 3 and 6 months. Results: With HE as the reference group, MI resulted in greater CT (OR = 3.0, 95% CI: 1.7–5.5) which was associated with better outcomes (average d =.34, SD =.13) and HE resulted in greater LT (OR =.05, 95%CI:.02–.10) which was also associated with better outcomes (average d =.42, SD =.08). Indirect parallel mediation effects on quit attempts were significant for both MI–CT (OR = 1.4, 95% CI: 1.1–1.7) and HE–LT (OR =.4, 95% CI:.2–.7). Conclusions: MI and HE were both efficacious via different pathways to change, confirming the utility of MI in this RCT aswell as highlighting the potential of HE based on the “5R’s” for smoking cessation.
| Original language | English |
|---|---|
| Pages (from-to) | 778-787 |
| Number of pages | 10 |
| Journal | Psychology of Addictive Behaviors |
| Volume | 35 |
| Issue number | 7 |
| DOIs | |
| State | Published - 2021 |
Funding
Accompanying the main report are Supplemental Materials for Online Publication which provide additional details including client language coding manuals. This manuscript is based on a secondary analysis of Catley et al. (American Journal of Preventive Medicine, 2016, 50(5), 573–583; Clinical-Trials.gov NCT01188018 October 2010), which was supported by National Cancer Institute Grants R01 CA133068. Pfizer provided varenicline (Chantix®) through Investigator-Initiated Research Support (No. WS759405). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or Pfizer. Catley, Goggin, and Resnicow received fees for providing motivational interviewing training. Catley received non-financial support from Pfizer. We thank Kathrene Conway,Mandy Seley, Niaman Nazir, and Vincent Staggs for their support
| Funders | Funder number |
|---|---|
| R01CA133068 | |
| Pfizer | WS759405 |
Keywords
- mediation
- motivational interviewing
- smoking cessation